摘要
目的分析应用孟鲁司特钠治疗小儿喘息性支气管炎的临床疗效。方法根据治疗方法将96例小儿喘息性支气管炎患儿分为46例对照组(常规治疗)和50例观察组(孟鲁司特钠治疗)。结果观察组临床总有效率分别92.00%高于对照组76.09%,观察组喘息消失时间(3.72±2.31)d、湿啰音消失时间(4.76±2.41)d、咳嗽消失时间(5.64±1.81)d、住院时间(6.73±2.41)d短于对照组(5.24±3.24)d、(6.98±2.54)d、(8.31±2.37)d、(9.36±3.15)d,观察组不良反应发生率6.0%,半年内复发率4.0%低于对照组15.2%、17.4%差异有统计学意义(P<0.05)。结论应用孟鲁司特钠治疗小儿喘息性支气管炎临床疗效确切,改善患儿临床症状显著。
Objective To analyze the clinical efficacy of montelukast in the treatment of asthmatic bronchitis in children.Methods According to the treatment method,96 children with asthmatic bronchitis were divided into 46 cases,the control group(routine treatment)and 50 cases of observation group(montelukast sodium treatment).Results The frequency of disappearance(3.72±2.31)d,the disappearance time of wet rales(4.76±2.41)d,the time of disappearance of cough(5.64±1.81)d,and the time of disappearance of cough were significantly higher than that of control group(76.09%),The time of hospitalization was(6.73±2.41)d shorter than that of the control group(5.24±3.24)d,(6.98±2.54)d,(8.31±2.37)d,(9.36±3.15)d;the incidence of adverse reactions in the observation group was 6.0%,and the recurrence rate was 4.0%lower than that in the control group at 15.2%,17.4%(P<0.05).Conclusion The clinical efficacy of montelukast in the treatment of children with asthmatic bronchitis is accurate,and the clinical symptoms of the patients are significantly improved.
作者
黎炳祥
王明义
方文
Li Bingxiang;Wang Mingyi;Fang Wen(Jiangmen City Xinhui Maternity and Children's Hospital,Jiangmen,Guangdong,529100,China)
出处
《当代医学》
2018年第13期14-17,共4页
Contemporary Medicine
